Zhejiang Xianju Pharmaceutical Co., Ltd. (SHE:002332)
China · Delayed Price · Currency is CNY 8.84
-0.04 (-0.45%)
Oct 28, 2026, 2:05 PM CST
SHE:002332 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,205 | 1,196 | 1,382 | 1,660 | 1,720 | 1,267 |
Trading Asset Securities | - | - | - | - | - | 500.64 |
Cash & Short-Term Investments | 1,205 | 1,196 | 1,382 | 1,660 | 1,720 | 1,768 |
Cash Growth | -7.79% | -13.45% | -16.76% | -3.51% | -2.67% | -8.79% |
Accounts Receivable | 1,050 | 1,051 | 856.66 | 726.38 | 706.37 | 752.24 |
Other Receivables | 23.97 | 89.22 | 45.86 | 15.41 | 70.84 | 17.66 |
Receivables | 1,074 | 1,141 | 902.52 | 741.79 | 777.21 | 769.9 |
Inventory | 895.68 | 914.38 | 930.86 | 922.88 | 890.5 | 910.7 |
Other Current Assets | 55.35 | 51.62 | 48.45 | 75.16 | 46.11 | 127.64 |
Total Current Assets | 3,231 | 3,303 | 3,264 | 3,400 | 3,434 | 3,576 |
Property, Plant & Equipment | 2,794 | 2,820 | 2,549 | 2,257 | 2,038 | 1,997 |
Long-Term Investments | 260.13 | 280.34 | 303.56 | 280.92 | 278.26 | 280.21 |
Goodwill | 588.6 | 636.02 | 581.21 | 606.96 | 573.27 | 557.57 |
Other Intangible Assets | 134.03 | 150.19 | 151.07 | 166.49 | 177.18 | 178.4 |
Long-Term Deferred Tax Assets | 35.28 | 32.85 | 28.76 | 21.62 | 28.61 | 25.39 |
Long-Term Deferred Charges | 13.06 | 16.54 | 11.2 | 10.16 | 10.19 | 12.55 |
Other Long-Term Assets | 23.44 | 19.87 | 110.78 | 249.99 | 197.84 | 101.12 |
Total Assets | 7,080 | 7,259 | 7,000 | 6,993 | 6,738 | 6,728 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 279.6 | 303.72 | 309.11 | 484.51 | 354.78 | 385.31 |
Accrued Expenses | 90.55 | 135.63 | 132.12 | 127.86 | 124.54 | 175.4 |
Short-Term Debt | 54.61 | 156.33 | 8.51 | 1.03 | 37.4 | 65.59 |
Current Portion of Long-Term Debt | 9.18 | 25.21 | 14.75 | 166.36 | 102.4 | 346.8 |
Current Portion of Leases | - | 5.64 | 4.92 | 3.47 | 6.37 | 6.22 |
Current Income Taxes Payable | 89.88 | 39.47 | 23.39 | 11 | 28.43 | 21.94 |
Current Unearned Revenue | 20.34 | 28.34 | 30.62 | 31.68 | 46.89 | 41.9 |
Other Current Liabilities | 320.09 | 354.65 | 254.67 | 221.01 | 268.26 | 346.94 |
Total Current Liabilities | 864.26 | 1,049 | 778.09 | 1,047 | 969.07 | 1,390 |
Long-Term Debt | 146.71 | 9.09 | 20.4 | 38.74 | 193.85 | 313.14 |
Long-Term Leases | 2.58 | 5.14 | 10.38 | 9.75 | 4.4 | 7.49 |
Long-Term Unearned Revenue | 113.14 | 102.66 | 97.25 | 57.86 | 54.53 | 59.28 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.23 | - |
Other Long-Term Liabilities | 12.73 | 10.89 | 205.29 | 9.53 | 8.49 | 8.31 |
Total Liabilities | 1,139 | 1,177 | 1,111 | 1,163 | 1,231 | 1,778 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 989.2 | 989.2 | 989.2 | 989.2 | 989.2 | 989.2 |
Additional Paid-In Capital | 1,852 | 1,852 | 1,841 | 1,820 | 1,803 | 1,802 |
Retained Earnings | 3,208 | 3,080 | 3,027 | 2,926 | 2,660 | 2,059 |
Comprehensive Income & Other | 0.36 | 113.58 | -13.52 | 50.61 | 5.74 | -15.98 |
Total Common Equity | 5,899 | 6,035 | 5,844 | 5,786 | 5,457 | 4,834 |
Minority Interest | 41.03 | 46.98 | 44.67 | 43.92 | 50.01 | 115.66 |
Shareholders' Equity | 5,940 | 6,082 | 5,888 | 5,830 | 5,507 | 4,950 |
Total Liabilities & Equity | 7,080 | 7,259 | 7,000 | 6,993 | 6,738 | 6,728 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 213.08 | 201.41 | 58.95 | 219.36 | 344.42 | 739.25 |
Net Cash (Debt) | 992.3 | 994.64 | 1,323 | 1,441 | 1,376 | 1,028 |
Net Cash Growth | -3.49% | -24.82% | -8.17% | 4.70% | 33.81% | 35.35% |
Net Cash Per Share | 1.00 | 1.00 | 1.33 | 1.46 | 1.39 | 1.04 |
Filing Date Shares Outstanding | 976.72 | 989.2 | 989.2 | 989.2 | 989.2 | 989.2 |
Total Common Shares Outstanding | 976.72 | 989.2 | 989.2 | 989.2 | 989.2 | 989.2 |
Working Capital | 2,367 | 2,254 | 2,486 | 2,353 | 2,465 | 2,186 |
Book Value Per Share | 6.04 | 6.10 | 5.91 | 5.85 | 5.52 | 4.89 |
Tangible Book Value | 5,177 | 5,249 | 5,111 | 5,013 | 4,707 | 4,098 |
Tangible Book Value Per Share | 5.30 | 5.31 | 5.17 | 5.07 | 4.76 | 4.14 |
Buildings | - | 1,266 | 1,154 | 1,112 | 977.17 | 1,025 |
Machinery | - | 2,404 | 2,025 | 1,803 | 275.36 | 1,506 |
Construction In Progress | - | 717.39 | 714.85 | 522.17 | 374.2 | 367.9 |